Vanta Bioscience is currently trading at Rs. 73.00, up by 2.10 points or 2.96% from its previous closing of Rs. 70.90 on the BSE.
The scrip opened at Rs. 70.50 and has touched a high and low of Rs. 73.25 and Rs. 70.10 respectively. So far 12000 shares were traded on the counter.
The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 75.35 on 27-Jun-2018 and a 52 week low of Rs. 41.40 on 12-Oct-2017.
Last one week high and low of the scrip stood at Rs. 73.25 and Rs. 64.00 respectively. The current market cap of the company is Rs. 40.15 crore.
The promoters holding in the company stood at 72.45%, while Non-Institutions held 27.55% stake in the company.
Vanta Bioscience has entered into an exclusive agreement with Hongkong Thinkway, Hong Kong to expand its business in the pre-clinical service sector in Greater China. The company has also entered into non-exclusive agreements to cover the markets of Latin America and Asia Pacific for Chemicals and Agro-chemical business.
These are lucrative markets and the Company expects over 25% at its revenues this year to come from this initiative.
Vanta Bioscience is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries
Company Name | CMP |
---|---|
Syngene Internation. | 915.70 |
Sagility India | 34.94 |
AGS Transact Tech | 79.93 |
Just Dial | 1119.55 |
Krystal Integrated | 769.90 |
View more.. |